How Dental Practice Brokers Work: A Seller’s Guide

Key Takeaways

• Selling a dental practice is usually the largest financial transaction in a dentist’s career, and the information gap between sellers and buyers can be one of the main reasons practice owners seek a dental practice broker.

• A disciplined six-step sell-side process with valuation, forecasting, confidential marketing, competitive bidding, negotiation, and quality-of-earnings defense can increase both price and likelihood of closing.

• Premier practices often benefit from a true side-by-side comparison of doctor-to-doctor and institutional buyer paths, because each buyer type can value the same practice differently.

• Structured competition among qualified buyers can produce final transaction values that average about 50 percent above initial unsolicited offers while still protecting confidentiality.

• McLerran & Associates provides sell-side advocacy that has closed roughly $2 billion in transactions at an 85–90 percent success rate; see what a competitive process could deliver for your practice with a free, confidential discovery call.

Six Steps McLerran Uses to Sell Premier Practices

A well-run dental practice sale follows a clear sequence. The six core steps are:

1. Comprehensive valuation and EBITDA analysis, with CPA-led, diligence-grade work that sets a defensible asking price before the practice goes to market.

2. Financial forecasting and path comparison, modeling real after-tax proceeds across doctor-to-doctor and institutional buyer scenarios so the owner can choose a path with fuller information.

3. Confidential go-to-market, building the marketing profile and data room, then reaching a vetted buyer pool without revealing the practice identity too early.

4. Structured competitive bid process, running an auction-style environment among qualified buyers to generate multiple offers and create competitive tension.

5. Negotiation, LOI, and deal structuring, advocating on every term such as cash at close, equity structure, earnout provisions, and employment terms.

6. Quality-of-earnings defense and closing, defending the agreed EBITDA through buyer diligence so the deal is less likely to be re-traded at the finish line.

The sections below walk through the most critical decision points in this process: understanding buyer options, creating competitive tension, finding the right partner, and maximizing the final outcome through thoughtful deal structure.

See how this six-step process applies to your practice with a free, confidential discovery call with McLerran & Associates.

Comparing Doctor and Institutional Buyer Paths

Before any marketing begins, a premier practice owner benefits from knowing what the practice is worth and in which market. Two structurally different buyer types exist, and they can value the same practice in different ways.

Doctor-to-doctor (private buyer) transactions often fit practices in roughly the $1–$1.5 million revenue range. Value in this lane is commonly expressed as a percentage of annual collections or a multiple of seller’s discretionary earnings (SDE, which means net income plus the owner’s salary, personal perks, and one-time expenses added back). The buyer is usually an individual dentist using SBA financing, and the transition is often a walk-away sale with a short work-back of about four to eight weeks.

Institutional buyer affiliation becomes more relevant as practice size and profitability grow. Institutional buyers value practices on adjusted EBITDA, which means earnings before interest, taxes, depreciation, and amortization, normalized to remove owner-specific expenses and one-time items. The same practice can produce materially different valuations depending on buyer type, so many owners want to understand both markets before committing to one.

McLerran & Associates works both paths in roughly equal measure, about a 50/50 split, and produces a side-by-side valuation that quantifies a practice’s worth in each market. Owners in the $1.5–$3 million revenue range often sit at a genuine crossroads where either path can be viable, and a real comparison can be one of the most reliable ways to choose.

Creating Real Competition for Your Practice

A seller who talks to one buyer has little leverage. A seller with ten competing offers has far more control. Structured competition can be one of the main factors that separates a strong outcome from an average one.

McLerran & Associates runs an auction-style bid process, typically 45 to 60 days, that often generates around ten offers per listing from a vetted, pre-qualified pool of buyers. Poorly run or undercapitalized buyers are removed before the process begins, so the competition is among serious, well-backed parties. U.S. dental practices taken to market through a structured multi-buyer process have achieved final transaction values averaging 50 percent above initial unsolicited offers, which illustrates what competitive tension can produce.

The process starts with an anonymized summary, then moves to staged disclosure behind non-disclosure agreements and buyer qualification. This structure helps protect staff, patients, and production while the competition runs. Confidential outreach that does not rely on a single inbound buyer can be a hallmark of a disciplined sell-side process.

Choosing a Buyer Who Fits Your Practice

The highest bidder is not always the best long-term partner. An institutional buyer deal usually creates a long-term relationship, because the seller typically continues working under a minimum five-year employment agreement. The buyer’s clinical philosophy, operational support model, and financial stability can matter as much as the headline number.

McLerran & Associates narrows the field from initial offers to in-person meetings with the top one to three finalists. The firm helps owners evaluate each buyer as both a financial partner and a steward of the practice’s legacy, staff, and patients. McLerran also helps owners review a buyer’s financial health by asking whether the organization is profitable, whether revenue is growing at existing locations, and whether the private equity backing it is experienced and well-capitalized. Partnering with an undercapitalized buyer can put a large share of retained equity at risk, and careful vetting can reduce that risk.

For doctor-to-doctor sales, fit usually means finding a buyer who will preserve the goodwill, patient relationships, and staff culture the selling dentist spent a career building.

Structuring a Deal That Maximizes Your Outcome

Maximizing outcome goes beyond the highest number on a letter of intent. A strong outcome can mean the number holds through diligence, the structure works for the seller, and the deal actually closes.

Institutional buyer offers are often complex. A typical deal combines cash at close, equity held at either the joint-venture level or the holding-company level, and an earnout tied to future performance targets. Because as much as 40 percent of a deal can be paid in equity rather than cash, and each structure can carry different risk and upside, comparing offers usually requires more than reading the headline number. This complexity is one of the main reasons McLerran produces multi-year, multi-structure financial forecasting, modeling real after-tax proceeds across deal structures and time horizons of 3, 5, 7, and 10 years, so owners can compare what a deal is actually worth, not just what it looks like on the cover page.

McLerran & Associates has completed approximately 2,000 successful practice sales representing roughly $2 billion in closed transaction volume, with a transaction rate of about 85 to 90 percent, compared to an industry norm closer to 35 to 40 percent. That close rate reflects diligence-grade valuation work done up front, structured competition, and hands-on advocacy through every stage of the deal.

Sell-Side Advocacy Compared With Standard Brokerage

Dental practice brokers do not all operate the same way. The table below contrasts several common approaches. Every figure is drawn from McLerran & Associates’ track record and publicly available industry data cited throughout this article.

Dimension	DIY / For-Sale-By-Owner	Local Generalist Broker	Multi-Vertical Advisor	“Free Valuation” Firm	McLerran & Associates
Dental specialization	None	Local only	Spread across verticals	Varies	Dental-only, national depth
Both sale paths	No	Usually one	Sometimes	Usually one	Both private-buyer and DSO, ~50/50
Valuation quality	Buyer-set anchor	Weak or informal	Variable	Free / napkin-math	CPA-led, diligence-grade, less likely to re-trade
Buyer pool	One buyer	1–2 DSOs or small list	Generic	Partial list	Large premier pool, with vetted and blacklisted DSOs
Competitive tension	None	Minimal	Some	Low	Structured auction, ~10 offers per listing
Transaction rate	~15–20% (DIY)	Below average	Variable	~35–40% (industry norm)	~85–90%

The core distinction is this: standard brokerage lists practices and waits. McLerran & Associates actively sells them by shaping the EBITDA story, creating competition among qualified buyers, and advocating for the seller from first conversation through closing.

What Dental Brokers Typically Charge

Dental practice broker fees are almost always structured as a success fee, which means the broker is paid only when the deal closes, not upfront. Some firms also charge a monthly retainer to cover marketing materials and buyer outreach, in addition to the success fee. Commissions are typically deducted at closing from the seller’s proceeds rather than paid directly by the buyer.

The more practical question for many owners is what the broker delivers relative to the fee. A qualified broker can often increase the final sale price by more than the commission through competitive buyers, professional marketing, and managed negotiation. A free valuation that anchors the deal at the wrong number, or a process that fails to close, can cost far more than any commission.

Why Premier Practices Often Use Dental Brokers

For a premier practice owner, the data suggests that using a broker can be beneficial. Do-it-yourself dental practice sales close at rates as low as 15 to 20 percent, compared to about 80 to 90 percent for a well-run brokered process. The gap exists because a practice sale can be fragile. It can fall apart at valuation, diligence, financing, or any point where an unrepresented seller may not have the experience to solve the problem.

Beyond close rates, the valuation gap can be significant. Buyer type and process structure directly affect valuation, and an owner negotiating directly with a single buyer, particularly a sophisticated institutional buyer, has no competitive tension, no EBITDA narrative control, and no quality-of-earnings defense when the buyer’s team reviews the numbers.

The practical decision often becomes which kind of broker to use. A dental-only sell-side advisor with a national, carefully vetted buyer pool, a CPA-led valuation process, and an 85 to 90 percent close rate can be a very different service from a local generalist who knows one or two buyers.

How Dental Brokers Are Paid

Dental practice brokers are paid by the seller, not the buyer, and payment usually depends on closing. Most sell-side dental M&A brokers work on a contingent basis and receive their success fee only when the transaction closes. This structure aligns the broker’s incentive with the seller’s outcome, because no close means no fee.

The success fee is deducted from the seller’s proceeds at closing. In transactions where a buyer’s representative is involved, the listing broker typically splits the commission, but the seller still pays the same total amount. Dual representation, where one broker represents both buyer and seller, does occur in dental transactions and warrants scrutiny, because the broker owes duties to both parties at the same time.

McLerran & Associates represents only the seller and never the buyer, so its incentives stay aligned with the practice owner’s outcome.

Institutional Equity, Earnouts, and Protecting EBITDA

Institutional buyer deal structures often require a level of financial literacy that most dentists have not needed before. Three components can deserve particular attention.

Equity can be held at two levels. Joint-venture equity sits at the practice level and typically pays distributions, which can create a higher floor but a lower ceiling. Holding-company equity sits at the buyer’s corporate level, pays no distributions, but can multiply several times over at the buyer’s next recapitalization event. JV, HoldCo, and hybrid equity structures are increasingly common in dental practice deals, so many sellers want to understand equity and earnout implications before signing a letter of intent.

Earnouts tie a portion of the purchase price to future performance, typically EBITDA targets over one to three years after closing. McLerran negotiates for non-punitive earnout terms, such as pro-rata provisions so a near-miss on a target still pays most of the earnout, and later start dates to account for integration disruption.

Quality-of-earnings (QoE) defense is where many deals quietly lose value. A QoE audit deployed by institutional buyers tests whether stated EBITDA is real, repeatable, and defensible by extracting raw data directly from practice management systems rather than relying on seller dashboards. A weak valuation analysis built on unsupported add-backs or aggressive normalizations can be challenged in diligence, and the deal can be re-traded downward. McLerran’s CPA-led EBITDA analysis is built to withstand that scrutiny, and the firm actively defends it when buyers push back.

Get a clear picture of your practice’s EBITDA and deal structure options with a free, confidential discovery call with McLerran & Associates.

Conclusion

How dental practice brokers work often comes down to whether they are listing your practice or actively selling it. Standard brokerage puts a practice on a list and waits. True sell-side advocacy shapes the EBITDA narrative, creates structured competition among qualified buyers, defends the valuation through diligence, and guides the owner from first conversation to closed deal.

McLerran & Associates’ track record, with an 85 to 90 percent close rate across $2 billion in transactions, reflects what a disciplined, dental-only sell-side process can produce. The firm works both the doctor-to-doctor and institutional buyer paths in roughly equal measure, so every client can see a genuine side-by-side comparison before choosing a direction.

Owners of premier dental practices who are thinking about a transition, now or in the next few years, often start by understanding what the practice is worth in both markets and what a competitive process could deliver.

Ready to understand what your practice is worth in both markets? Schedule a free, confidential discovery call with McLerran & Associates or call (512) 900-7989, email info@dentaltransitions.com, or visit dentaltransitions.com/contact-us. Not ready to sell yet? Join the McLerran M&A Summit on October 29–30, 2026, get educated before you decide, and receive a complimentary practice valuation (a $2,500 value).

Frequently Asked Questions

What is the difference between a dental practice broker and a sell-side advisor?

A traditional dental practice broker primarily focuses on listing a practice and connecting sellers with buyers, which can be a relatively passive role that ends when an introduction is made. A sell-side advisor and advocate manages the entire transaction on the seller’s behalf by building a diligence-grade valuation, running a structured competitive bid process, negotiating every term of the letter of intent, and defending the agreed value through the buyer’s due diligence review. The distinction can matter because the advisor’s involvement, or lack of it, can directly affect both the price achieved and the probability that the deal closes. McLerran & Associates operates exclusively as a sell-side advisor and never represents the buyer, which keeps its incentives aligned with the practice owner’s outcome.

How long does it typically take to sell a dental practice?

The timeline varies by transaction type and practice complexity. A doctor-to-doctor sale commonly takes six to nine months from initial engagement through closing. A DSO or private equity affiliation can take nine to 18 months, depending on the buyer’s diligence process and deal structure. Within those ranges, McLerran’s DSO bid process typically runs 45 to 60 days from go-to-market to a shortlist of finalists, after which negotiation, diligence, and closing proceed. Owners who begin the process with organized financials, a clean lease, and a clear transition plan tend to move faster. McLerran will also update a practice valuation for free one year later if an owner completes the initial evaluation but is not yet ready to proceed, so starting the conversation early carries little downside.

Should I sell to a private buyer or affiliate with a DSO?

The right path depends on your practice’s size, profitability, and your personal goals for life after the sale. Practices in roughly the $1–$1.5 million revenue range often fit a doctor-to-doctor sale, where the buyer is an individual dentist who preserves the practice’s culture and the seller typically exits within weeks. Larger practices, particularly those above $1.5 million in revenue, are more likely to attract institutional interest, where the economics of a DSO affiliation can be higher but usually require the seller to continue working under a multi-year employment agreement.

Practices in the $1.5–$3 million revenue range often sit at a crossroads where either path may be viable. Because McLerran works both markets in roughly equal measure, it produces a true side-by-side valuation so owners can compare real after-tax proceeds across both paths, including the option of keeping the practice, before making a decision.

What makes a dental practice valuation “diligence-grade”?

A diligence-grade valuation is one that can hold up when a sophisticated buyer’s financial team examines it. Every add-back, which means the adjustments that convert tax-optimized reported income into true operating profitability, is documented, defensible, and consistent with what institutional buyers commonly accept. Common add-backs include owner compensation normalized to a market-rate associate equivalent, one-time or non-recurring expenses, personal expenses run through the practice, and non-cash charges like depreciation.

Add-backs that are aggressive, undocumented, or inconsistent with industry norms can be challenged or removed during a buyer’s quality-of-earnings review, which can trigger a significant downward adjustment to the agreed price. McLerran’s CPA-led EBITDA analysis is built to the standard that institutional buyers apply, so the number that goes to market is more likely to be the number that survives diligence and the deal is less likely to be re-traded at the finish line.

How does McLerran & Associates protect staff and patients during a sale?

Confidentiality is the primary protection. McLerran markets practices anonymously, without disclosing the practice’s name or exact location, and requires prospective buyers to sign non-disclosure agreements and pass financial vetting before receiving any identifying information. Showings are typically scheduled outside business hours to reduce the chance of staff or patient awareness before the seller is ready to communicate.

Beyond confidentiality, McLerran acts as a buffer between the seller and buyer throughout the process, managing communications and negotiations so the selling dentist can continue running the practice normally. On the buyer side, finding the right fit, not just the highest bid, is a central part of McLerran’s mandate. The firm steers owners toward buyers whose operational philosophy, support model, and track record suggest they will protect the legacy, staff, and patients the seller is leaving behind.